These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phosphoramidon-sensitive endothelin converting enzyme in cultured vascular smooth muscle cells converts big endothelin-3 to endothelin-3. Tsukahara Y, Matsumura Y, Kuninobu K, Kojima T, Takaoka M, Morimoto S. Life Sci; 1993; 53(6):465-71. PubMed ID: 8341132 [Abstract] [Full Text] [Related]
6. Endothelin-2-converting enzyme from human renal adenocarcinoma cells is a phosphoramidon-sensitive, membrane-bound metalloprotease. Shinmi O, Yorimitsu K, Moroi K, Nishiyama M, Sugita Y, Saito T, Inagaki Y, Masaki T, Kimura S. J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S61-4. PubMed ID: 7510000 [Abstract] [Full Text] [Related]
7. Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts. Patel KV, Schrey MP. Br J Cancer; 1995 Mar; 71(3):442-7. PubMed ID: 7880721 [Abstract] [Full Text] [Related]
13. A comparison of endothelin-converting enzyme activity from primary porcine aortic endothelial cells with activities in cultured human cell lines. Knap AK, Wigg AM. J Cardiovasc Pharmacol; 1993 Jun; 22 Suppl 8():S90-3. PubMed ID: 8121180 [Abstract] [Full Text] [Related]
14. Biochemical properties of endothelin converting enzyme in renal epithelial cell lines. Takada J, Hata M, Okada K, Matsuyama K, Yano M. Biochem Biophys Res Commun; 1992 Feb 14; 182(3):1383-8. PubMed ID: 1540181 [Abstract] [Full Text] [Related]
15. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Woods M, Mitchell JA, Wood EG, Barker S, Walcot NR, Rees GM, Warner TD. Mol Pharmacol; 1999 May 14; 55(5):902-9. PubMed ID: 10220569 [Abstract] [Full Text] [Related]
16. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway. Yorimitsu K, Shinmi O, Nishiyama M, Moroi K, Sugita Y, Saito T, Inagaki Y, Masaki T, Kimura S. FEBS Lett; 1992 Dec 21; 314(3):395-8. PubMed ID: 1468574 [Abstract] [Full Text] [Related]
17. Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1a. Kulathila R, Clark K, Savage P, Bowen BR, Emoto N, Yanagisawa M, Jeng AY. Clin Sci (Lond); 2002 Aug 21; 103 Suppl 48():94S-97S. PubMed ID: 12193063 [Abstract] [Full Text] [Related]
18. Identification and characterization of endothelin converting activity from EAHY 926 cells: evidence for the physiologically relevant human enzyme. Waxman L, Doshi KP, Gaul SL, Wang S, Bednar RA, Stern AM. Arch Biochem Biophys; 1994 Jan 21; 308(1):240-53. PubMed ID: 8311460 [Abstract] [Full Text] [Related]
19. Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon. Keller PM, Lee CP, Fenwick AE, Atkinson ST, Elliott JD, DeWolf WE. Biochem Biophys Res Commun; 1996 Jun 14; 223(2):372-8. PubMed ID: 8670289 [Abstract] [Full Text] [Related]
20. Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. Okada K, Takada J, Arai Y, Matsuyama K, Yano M. Biochem Biophys Res Commun; 1991 Oct 31; 180(2):1019-23. PubMed ID: 1953706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]